Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
1.210
+0.010 (0.83%)
At close: Mar 9, 2026, 4:00 PM EDT
1.200
-0.010 (-0.83%)
After-hours: Mar 9, 2026, 4:10 PM EDT
Rein Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 32 | 50 | 15 | 11 | 51 | 42 | |
| Market Cap Growth | -46.08% | 234.56% | 38.39% | -78.89% | 20.50% | 165.52% | |
| Enterprise Value | 27 | 77 | 3 | -15 | -1 | 33 | |
| Last Close Price | 1.20 | 2.30 | 3.05 | 2.37 | 11.26 | 20.80 | |
| PB Ratio | 25.46 | 0.92 | 0.15 | 0.58 | 1.16 | 3.48 | |
| P/TBV Ratio | - | - | - | 0.58 | 1.16 | 3.48 | |
| Debt / Equity Ratio | - | - | 0 | 0.00 | 0.00 | 0.03 | |
| Net Debt / Equity Ratio | -0.09 | -0.24 | -0.18 | -1.14 | -1.04 | -1.10 | |
| Net Debt / EBITDA Ratio | 0.17 | 0.46 | 1.13 | 0.77 | 1.73 | 0.66 | |
| Net Debt / FCF Ratio | 0.19 | 0.58 | 0.87 | 0.85 | 1.91 | 0.66 | |
| Quick Ratio | 0.71 | 2.24 | 3.95 | 6.28 | 10.19 | 3.49 | |
| Current Ratio | 0.90 | 2.38 | 4.17 | 6.46 | 10.69 | 4.12 | |
| Return on Equity (ROE) | -83.28% | -82.37% | -26.91% | -87.41% | -93.33% | -150.00% | |
| Return on Assets (ROA) | -18.81% | -20.89% | -14.99% | -49.03% | -51.30% | -59.84% | |
| Return on Capital Employed (ROCE) | -49.60% | -49.80% | -15.10% | -148.50% | -60.50% | -165.50% | |
| Earnings Yield | -186.68% | -126.19% | -105.62% | -253.93% | -51.32% | -50.00% | |
| FCF Yield | -66.43% | -44.73% | -132.99% | -231.03% | -46.90% | -48.41% | |
| Buyback Yield / Dilution | -71.80% | -290.09% | -1.31% | -2.23% | -154.70% | -42.11% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.